Search results
Results from the WOW.Com Content Network
Potentilla recta, the sulphur cinquefoil [1] or rough-fruited cinquefoil, is a species of cinquefoil. It is native to Eurasia but it is present in North America as an introduced species, ranging through almost the entire continent except the northernmost part of Canada and Alaska. The plant probably originated in the Mediterranean Basin.
Potentilla pensylvanica (P. pensylvanica)is a species of cinquefoil known by the common names Pennsylvania cinquefoil [1] and prairie cinquefoil [2] and in the language Shoshoni, it goes by the name Ku'-si-wañ-go-gǐp. It is native to much of northern and western North America, including most of Canada and the western half of the United States.
Potentilla / ˌ p oʊ t ən ˈ t ɪ l ə / [1] is a genus containing over 500 species of annual, biennial and perennial herbaceous flowering plants in the rose family, Rosaceae.. Potentillas may also be called cinquefoils in English, but they have also been called five fingers and silverweeds.
Drymocallis is a genus of plants formerly (and sometimes still) included with the typical cinquefoils (Potentilla).It contains three species known or suspected to be protocarnivorous, [1] but more cinquefoils might eventually be moved here: [2] [3]
Potentilla pseudosericea is a species of cinquefoil known by the common names silky cinquefoil [1] and Mono cinquefoil. It is native to the Sierra Nevada of California and mountain ranges just to the east, where its distribution extends into Nevada .
Potentilla diversifolia or Potentilla × diversifolia is a species of flowering plant in the Rose Family known by the common names varileaf cinquefoil, [1] different-leaved cinquefoil, [citation needed] and mountain meadow cinquefoil.
better glycemic control to reduce the incidence and severity of the complications of diabetes. Major disadvantages of intensive/flexible therapy are that it requires greater amounts of education and effort to achieve the goals, and it increases the daily cost for glucose monitoring four or more times a day.
A 2011 Cochrane review found evidence that treatment of LADA using sulfonylureas lead to earlier insulin dependence in approximately 30% of cases. [ 10 ] A 2014 Cochrane review found tentative evidence that people treated with sulfonylureas have fewer non-fatal cardiovascular events than those treated with metformin (RR 0.7) but a higher risk ...